| Application no. and date | 11784992.7 (espacenet) (Federated) (European Patent Register), 20111115 | | Patent/reg. no. and date | DK/EP 2640718, 20180328 | | Publication date | 20130925 | | Priority no. and date | DE 102010044131, 20101118 | | EP pub. no. and date |
EP 2640718 20130925 | | Effective date | | | Applicant/owner | Bayer Intellectual Property GmbH, Alfred-Nobel-Str. 50
40789 Monheim am Rhein, DE | | Applicant ref. no. | BBS BHC101047PCT-EP | | Inventor | Militzer, Hans-Christian, Waldweg 2
51519 Odenthal, DE,
GRIES, Jörg, August-Macke-Weg 34
42781 Haan, DE,
KOEP, Stefan, Saarlandring 31
58256 Ennepetal, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 9/00 (2006.01) , C07D 403/14 (2006.01) | | Title | SUBSTITUERET NATRIUM-1H-PYRAZOL-5-OLAT | | Int. application no. | EP2011070099 | | Int. publication no. | WO2012065967 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
